A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION.
Clinical trial NCT04971512 · TERMINATED
Trial details
- NCT number
- NCT04971512
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-02
- Primary completion
- 2021-12-20
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.